Loading...
 
Back to the list
Mediterr J Rheumatol 2022;33(3):349-60
Article Links
Immune-Mediated Inner Ear Disease Associated with Type 1 Autoimmune Hepatitis: A Challenging Coexistence
Athina Zarachi1, Eleftherios Pelechas2, Alkistis Tsikou1, Georgios N. Kalambokis3, Aikaterini Zioga4, Katerina E. Panteli3, Iro Rapti3, Sempastian Filippas-Ntekouan3, Ioannis Kastanioudakis1, Fotini B. Karassa2
Authors Information

1Department of Otorhinolaryngology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

2Department of Rheumatology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

 31st Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

4Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

A Zarachi, E Pelechas, I Rapti, S Filippas-Ntekouan, I Kastanioudakis, FB Karassa

Keywords: immune-mediated inner ear disease, type 1 autoimmune hepatitis
References
  1. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
  2. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008;48:1540-8.
  3. Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 2020;72:671-722.
  4. Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers 2018;4:18017.
  5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol 2015;63:971-1004
  6. Das S, Bakshi SS, Seepana R. Demystifying autoimmune inner ear disease. Eur Arch Otorhinolaryngol 2019;276:3267-74.
  7. Ciorba A, Corazzi V, Bianchini C, Aimoni C, Pelucchi S, Skarżyński PH, et al. Autoimmune inner ear disease (AIED): A diagnostic challenge. Int J Immunopathol Pharmacol 2018;32:2058738418808680.
  8. Ralli M, D'Aguanno V, Di Stadio A, De Virgilio A, Croce A, Longo L, et al. Audiovestibular Symptoms in Systemic Autoimmune Diseases. J Immunol Res 2018;2018:5798103.
  9. Goodall AF, Siddiq MA. Current understanding of the pathogenesis of autoimmune inner ear disease: a review. Clin Otolaryngol 2015;40:412-9.
  10. Rahne T, Plontke S, Keyßer G. Vasculitis and the ear: a literature review. Curr Opin Rheumatol 2020;32:47-52.
  11. Gatselis NK, Zachou K, Papamichalis P, Koukoulis GK, Babeta S, Dalekos GN, et al. Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis 2010;42:807-12.
  12. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76.
  13. Dalekos GN, Koskinas J, Papatheodoridis GV. Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis. Ann Gastroenterol 2019;32:1-23.
  14. Hartl J, Miquel R, Zachou K, Wong GW, Asghar A, Pape S, et al. Features and outcome of AIH patients without elevation of IgG. JHEP Rep 2020;2:1000094.
  15. Sebode M, Hartl J, Vergani D, Lohse AW; International Autoimmune Hepatitis Group (IAIHG). Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda. Liver Int 2018;38:15-22.
  16. Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci 2011;56:545-54.
  17. Miao Q, Bian Z, Tang R, Zhang H, Wang Q, Huang S, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015;48:226-35.
  18. Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol 2022;19:158-76.
  19. Takahashi A, Arinaga-Hino T, Ohira H, Abe K, Torimura T, Zeniya M, et al. Non-alcoholic fatty liver disease in patients with autoimmune hepatitis. JGH Open 2018;2:54-8.
  20. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28:296-301.
  21. Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet 2018;391:2547-59.
  22. Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, et al. The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun 2019;105:102328.
  23. Trojanowska A, Drop A, Trojanowski P, Rosińska-Bogusiewicz K, Klatka J, Bobek-Billewicz B. External and middle ear diseases: radiological diagnosis based on clinical signs and symptoms. Insights Imaging 2012;3:33-48.
  24. Altissimi G, Colizza A, Cianfrone G, de Vincentiis M, Greco A, Taurone S, et al. Drugs inducing hearing loss, tinnitus, dizziness and vertigo: an updated guide. Eur Rev Med Pharmacol Sci 2020;24:7946-52.
  25. Salihoğlu M, Turhan V, Önem Y, Ulcay A, Uzun G, Ay H. Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection. Scand J Infect Dis 2013;45:239-40.
  26. Talwani R, Gilliam BL, Howell C. Infectious diseases and the liver. Clin Liver Dis 2011;15:111-30.
  27. Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol 2020;72:7-19.
  28. Drazilova S, Veseliny E, Lenartova PD, Drazilova D, Gazda J, Grgurevic I, et al. IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease. Can J Gastroenterol Hepatol 2021;2021:1959832.
  29. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 2015;385:1460-71.
  30. Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067.
  31. Girasoli L, Cazzador D, Padoan R, Nardello E, Felicetti M, Zanoletti E, et al. Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment. J Immunol Res 2018;2018:5072582.
  32. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
  33. Espinoza GM, Wheeler J, Temprano KK, Keller AP. Cogan's Syndrome: Clinical Presentations and Update on Treatment. Curr Allergy Asthma Rep 2020;20:46.
  34. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
  35. Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Lerma-Márquez JL. Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. Rheumatology (Oxford) 2011;50:1414-23.
  36. Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun 2014;48-49:84-9.
  37. Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 2014;371:50-7.
  38. Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, et al. Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1878-901.
  39. Llanos O, Hamzeh N. Sarcoidosis. Med Clin North Am 2019;103:527-34.
  40. Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, et al. Behçet's disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev 2018;17:567-75.
  41. Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009;8:192-204.
  42. Adiga A, Nugent K. Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis). Am J Med Sci 2017;353:329-35.
  43. Grasland A, Pouchot J, Hachulla E, Blétry O, Papo T, Vinceneux P; Study Group for Cogan’s Syndrome. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 2004;43:1007-15.
  44. Weyand CM, Goronzy JJ. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 2014;371:50-7.
  45. Lee S, Childerhouse A, Moss K. Gastrointestinal symptoms and granulomatous vasculitis involving the liver in giant cell arteritis: a case report and review of the literature. Rheumatology (Oxford) 2011;50:2316-7.
  46. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
  47. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 2019;78:1151-9.
  48. Kumar M, Herrera JL. Sarcoidosis and the Liver. Clin Liver Dis 2019;23:331-43.
  49. Tanaka A et al. Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: A histopathological and clinical perspective. Hepatol Res 2021;51:850-9.
  50. Carlson ML. Cochlear Implantation in Adults. N Engl J Med 2020;382:1531-42.
  51. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396:413-46.
  52. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
  53. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-213.
  54. Breslin NK, Varadarajan VV, Sobel ES, Haberman RS. Autoimmune inner ear disease: A systematic review of management. Laryngoscope Investig Otolaryngol 2020;5:1217-26.
  55. Bovensiepen CS, Schakat M, Sebode M, Zenouzi R, Hartl J, Peiseler M, et al. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis. J Immunol 2019;203:3148-56.
  56. Yehudai D, Shoenfeld Y, Toubi E. The autoimmune characteristics of progressive or sudden sensorineural hearing loss. Autoimmunity 2006;39:153-8.
  57. Strum D, Kim S, Shim T, Monfared A. An update on autoimmune inner ear disease: A systematic review of pharmacotherapy. Am J Otolaryngol 2020;41:102310.
  58. Hu BH, Zhang C, Frye MD. Immune cells and non-immune cells with immune function in mammalian cochleae. Hear Res 2018;362:14-24.
  59. Vélez-Ortega AC, Frolenkov GI. Building and repairing the stereocilia cytoskeleton in mammalian auditory hair cells. Hear Res 2019;376:47-57.
  60. Barr-Gillespie PG. Assembly of hair bundles, an amazing problem for cell biology. Mol Biol Cell 2015;26:2727-32.
  61. Drummond MC, Barzik M, Bird JE, Zhang DS, Lechene CP, Corey DP, et al. Live-cell imaging of actin dynamics reveals mechanisms of stereocilia length regulation in the inner ear. Nat Commun 2015;6:6873.